Literature DB >> 9150352

The human bladder carcinoma cell line 5637 constitutively secretes functional cytokines.

H Quentmeier1, M Zaborski, H G Drexler.   

Abstract

We have studied cytokine secretion by the human bladder carcinoma cell line 5637 using growth factor-dependent cell line bioassays and specific ELISA. The 5637 cell line-conditioned medium (5637 CM) stimulated proliferation of human growth factor-dependent leukemia cell lines in a dose-dependent fashion. Quantitation by specific ELISA and by bioassays detected high amounts of G-CSF and GM-CSF and smaller quantities of IL-1beta, M-CSF and SCF in 5637 CM; the concentration of IL-3 was below the detection level of the ELISA, if present at all. The G-CSF and GM-CSF activities secreted by 5637 cells could be inhibited specifically by neutralizing anti-G-CSF and anti-GM-CSF antibodies. In conclusion, 5637 bladder carcinoma cells constitutively produce and secrete several functionally active cytokines; 5637 CM is a valuable, reliable and inexpensive source for cytokines, for instance for the culture of growth factor-responsive or -dependent hematopoietic primary cells and cell lines.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9150352     DOI: 10.1016/s0145-2126(96)00132-4

Source DB:  PubMed          Journal:  Leuk Res        ISSN: 0145-2126            Impact factor:   3.156


  24 in total

1.  Cytotoxic necrotizing factor type 1 of uropathogenic Escherichia coli kills cultured human uroepithelial 5637 cells by an apoptotic mechanism.

Authors:  M Mills; K C Meysick; A D O'Brien
Journal:  Infect Immun       Date:  2000-10       Impact factor: 3.441

2.  Binding of Released Bim to Mcl-1 is a Mechanism of Intrinsic Resistance to ABT-199 which can be Overcome by Combination with Daunorubicin or Cytarabine in AML Cells.

Authors:  Xiaojia Niu; Jianyun Zhao; Jun Ma; Chengzhi Xie; Holly Edwards; Guan Wang; J Timothy Caldwell; Shengyan Xiang; Xiaohong Zhang; Roland Chu; Zhihong J Wang; Hai Lin; Jeffrey W Taub; Yubin Ge
Journal:  Clin Cancer Res       Date:  2016-04-21       Impact factor: 12.531

3.  Inhibition of CDK9 by voruciclib synergistically enhances cell death induced by the Bcl-2 selective inhibitor venetoclax in preclinical models of acute myeloid leukemia.

Authors:  Daniel A Luedtke; Yongwei Su; Jun Ma; Xinyu Li; Steven A Buck; Holly Edwards; Lisa Polin; Juiwanna Kushner; Sijana H Dzinic; Kathryn White; Hai Lin; Jeffrey W Taub; Yubin Ge
Journal:  Signal Transduct Target Ther       Date:  2020-02-26

4.  Inhibition of Bcl-2 Synergistically Enhances the Antileukemic Activity of Midostaurin and Gilteritinib in Preclinical Models of FLT3-Mutated Acute Myeloid Leukemia.

Authors:  Jun Ma; Shoujing Zhao; Xinan Qiao; Tristan Knight; Holly Edwards; Lisa Polin; Juiwanna Kushner; Sijana H Dzinic; Kathryn White; Guan Wang; Lijing Zhao; Hai Lin; Yue Wang; Jeffrey W Taub; Yubin Ge
Journal:  Clin Cancer Res       Date:  2019-07-18       Impact factor: 12.531

5.  Expression of granulocyte colony stimulating factor receptor in human colorectal cancer.

Authors:  X Yang; F Liu; Z Xu; C Chen; X Wu; G Li; J Li
Journal:  Postgrad Med J       Date:  2005-05       Impact factor: 2.401

6.  Synergistic anti-leukemic interactions between ABT-199 and panobinostat in acute myeloid leukemia ex vivo.

Authors:  Jonathan Schwartz; Xiaojia Niu; Eric Walton; Laura Hurley; Hai Lin; Holly Edwards; Jeffrey W Taub; Zhihong Wang; Yubin Ge
Journal:  Am J Transl Res       Date:  2016-09-15       Impact factor: 4.060

7.  Increase in gamma-globin mRNA content in human erythroid cells treated with angelicin analogs.

Authors:  Ilaria Lampronti; Nicoletta Bianchi; Cristina Zuccato; Francesco Dall'Acqua; Daniela Vedaldi; Giampietro Viola; Rocco Potenza; Francesco Chiavilli; Giulia Breveglieri; Monica Borgatti; Alessia Finotti; Giordana Feriotto; Francesca Salvatori; Roberto Gambari
Journal:  Int J Hematol       Date:  2009-09-25       Impact factor: 2.490

8.  Expression of granulocyte colony-stimulating factor receptor in rectal cancer.

Authors:  Xiao-Dong Yang; Ping Huang; Feng Wang; Ze-Kuan Xu
Journal:  World J Gastroenterol       Date:  2014-01-28       Impact factor: 5.742

9.  Synthesis and Antileukemic Activities of Piperlongumine and HDAC Inhibitor Hybrids against Acute Myeloid Leukemia Cells.

Authors:  Yi Liao; Xiaojia Niu; Bailing Chen; Holly Edwards; Liping Xu; Chengzhi Xie; Hai Lin; Lisa Polin; Jeffrey W Taub; Yubin Ge; Zhihui Qin
Journal:  J Med Chem       Date:  2016-08-24       Impact factor: 7.446

10.  Synergistic anti-leukemic interactions between panobinostat and MK-1775 in acute myeloid leukemia ex vivo.

Authors:  Wenxiu Qi; Wenbo Zhang; Holly Edwards; Roland Chu; Gerard J Madlambayan; Jeffrey W Taub; Zhihong Wang; Yue Wang; Chunhuai Li; Hai Lin; Yubin Ge
Journal:  Cancer Biol Ther       Date:  2015       Impact factor: 4.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.